AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kos, V. N.
Right arrow Articles by Taylor, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kos, V. N.
Right arrow Articles by Taylor, D. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2006, p. 778-780, Vol. 50, No. 2
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.2.778-780.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Antimicrobial Susceptibilities of Campylobacter jejuni Isolates from Poultry from Alberta, Canada

Veronica N. Kos,1 Monika Keelan,2,3 and Diane E. Taylor1*

Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada,1 Department of Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada,2 Laboratory of Foodborne Zoonoses, Public Health Agency of Canada, Edmonton, Alberta, Canada3

Received 25 July 2005/ Returned for modification 9 September 2005/ Accepted 8 November 2005


   ABSTRACT
Top
 Abstract
Text
 References
 
One hundred four isolates of Campylobacter jejuni from poultry in Alberta, Canada, collected during 2001 were tested for resistance to 10 antimicrobial agents using agar dilution. This study provides a baseline of resistance profiles and the mechanisms of resistance observed in C. jejuni in poultry from Alberta, Canada.


   TEXT
Top
 Abstract
 Text
References
 
Campylobacter jejuni is a major food- and waterborne pathogen associated with gastroenteritis worldwide (6). Human C. jejuni infection occurs primarily through consumption of or contact with raw or undercooked poultry (5, 6, 21). The increased incidence of antimicrobial resistance in C. jejuni over the past 2 decades (6, 7, 11) is likely due to the agricultural use of antimicrobials for prophylaxis and growth promotion (10, 24).

Baseline levels of antimicrobial resistance in C. jejuni from environmental sources would be useful in developing policies regulating the use of antimicrobials in food production and human therapies. This study reports the susceptibility profiles of 104 C. jejuni isolates obtained from peptone washes of retail broilers from Alberta, Canada (Agri-Food Laboratories, Alberta Agriculture), to 10 antimicrobial agents in 2001 and the mechanisms of resistance present in resistant isolates.

Etest and disk diffusion methods were used to screen isolates for resistance to tetracycline, erythromycin, chloramphenicol, nalidixic acid, ciprofloxacin, kanamycin, imipenem, doxycycline, gentamicin, and amoxicillin-clavulanic acid (8). Any discrepancies in results were investigated by agar dilution. At the time this study was completed, breakpoint criteria for C. jejuni were not available, nor was there a designated C. jejuni control strain (17). Representative bacterial cutoffs were used as outlined by the Clinical and Laboratory Standards Institute (19). Control strains included several C. jejuni isolates for which MICs are well established in our laboratory (25).

The gyrA gene in ciprofloxacin-resistant isolates (28) and a fragment of the tet(O) gene in tetracycline-resistant isolates (11) were amplified by PCR. Plasmid and chromosomal DNAs were used as templates for tet(O) gene PCR, as the gene has been found to integrate into the chromosome (11, 22). The entire tet(O) gene (1.92 kbp) was analyzed as described by Gibreel et al. (11) from C. jejuni strains whose tetracycline MICs fell between 128 and 512 µg/ml.

Tetracycline resistance was observed in 69% (72/104) of the isolates, with MICs of 64 to 128 µg/ml for 49 isolates and 256 to 512 µg/ml for 6 isolates. Doxycyline resistance was observed in 64 poultry isolates, with MICs of 128 µg/ml for 7 isolates and 256 µg/ml for 1 isolate.

Approximately 11% (11/104) of the isolates were resistant to nalidixic acid, with MICs of 128 to 256 µg/ml for 7 isolates. Ciprofloxacin resistance was observed in 8% of the isolates (8/11 nalidixic acid-resistant isolates), with MICs of 32 µg/ml for 4 isolates.

All isolates were susceptible to amoxicillin-clavulanic acid, chloramphenicol, gentamicin, imipemen, kanamycin, and erythromycin. Multidrug resistance was observed in nine isolates, with six isolates being resistant to tetracycline, doxycycline, and both fluoroquinolones. One isolate was resistant to the tetracyclines and nalidixic acid. Two isolates were resistant to tetracycline and both fluoroquinolones (Table 1).


View this table:
[in this window]
[in a new window]
  		TABLE 1. MICs of multidrug-resistant isolates of C. jejuni, as determined by agar dilution

 
Seven ciprofloxacin-resistant isolates contained a C-to-T transition at nucleotide position 256 of the gyrA gene (codon 86; Thr->Ile), which is known to mediate high levels of quinolone resistance in Campylobacter (28). One isolate did not possess the mutation but was resistant to 4 µg/ml of ciprofloxacin.

The tet(O) gene was carried on a plasmid in 67 of 72 tetracycline-resistant isolates and on the chromosome in 5 isolates. In comparison with the original tet(O) gene sequence (16) from an isolate with a lower MIC (64 µg/ml), the tet(O) sequences of 21 high-level tetracycline-resistant poultry isolates revealed seven base changes in three isolates with MICs of 128 µg/ml, 256 µg/ml, and 512 µg/ml, as reported previously (11) (Table 2). Another isolate (MIC, 128 µg/ml) had six of the seven base changes, with the T910C transition absent. A C704T base change, which results in a change from alanine to valine, was present in 12 of 15 tetracycline-resistant isolates (MIC, 128 µg/ml). The various MICs for the strains with these base changes suggest that the substitutions may not be solely responsible for conferring tetracycline resistance at 512 µg/ml but may have some effect on the expression of tet(O) or the function of tetracycline resistance determinants in isolates resistant to tetracycline at 128 to 256 µg/ml.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Base pair and subsequent amino acid changes detected in sequenced tet(O) genes of 21 tetracycline-resistant C. jejuni isolates

 
Antimicrobial resistance in C. jejuni is increasing globally (2, 4, 10, 13, 23, 26) and is reflected in clinical isolates from Canada (7, 11). Fluoroquinolone-resistant C. jejuni appeared following the introduction of enrofloxacin and sarafloxacin in the 1990s to treat poultry for Escherichia coli infections (1, 9, 10, 14, 18, 27). Ciprofloxacin-resistant C. jejuni has been suggested to be more fit and preferentially selected in the guts of chicks without any antibiotic selective pressure (15). The appearance of ciprofloxacin-resistant isolates is of concern, as this antibiotic is widely used for the empirical treatment of gastroenteritis and is recommended for the treatment of infections caused by macrolide-resistant Campylobacter (6).

The use of tetracyclines such as doxycycline in agriculture is likely responsible for the large number of tetracycline-resistant C. jejuni isolates. One study suggested that the tet(O) gene may be rapidly and spontaneously transferred in vivo without antimicrobial selection pressure between C. jejuni strains in the digestive tracts of chickens (3). Surveillance of tetracycline resistance is important due to the potential for plasmid-mediated transfer of the tet(O) gene (25) as well as genes encoding resistance to other antimicrobials (20) for other potential pathogens.

While multidrug resistance in C. jejuni isolates from poultry (9/104) is not common, the report of multidrug-resistant conjugative plasmids within C. jejuni (20) combined with the minimal regulation of antimicrobial usage (12) may result in the appearance of more such isolates.

Although poultry is suspected to be the primary source of C.jejuni infections for humans, other environmental sources such as water, wildlife, and cattle may also be important. The high incidence of plasmid-mediated tetracycline resistance and the emergence of ciprofloxacin resistance in C. jejuni poultry isolates support the need for antimicrobial resistance surveillance in order to develop policies regulating the use of antimicrobials in food production and human therapies.


   ACKNOWLEDGMENTS
 
This research was supported by funding from the National Science and Engineering Research Council (NSERC), Alberta Heritage Foundation for Medical Research (AHFMR), and Canadian Institutes of Health Research (Safe Food and Water Initiative). D.E.T. is an AHFMR Scientist.


   FOOTNOTES
 
* Corresponding author. Mailing address: Department of Medical Microbiology and Immunology, 1-28 Medical Science Building, University of Alberta, Edmonton, Alberta, Canada T6G 2H7. Phone: (780) 492-4777. Fax: (780) 492-7521. E-mail: diane.taylor{at}ualberta.ca. Back


   REFERENCES
Top
 Abstract
 Text
 References
 

  1. Allos, B. M. 2001. Campylobacter jejuni infections: update on emerging issues and trends. Clin. Infect. Dis. 32:1201-1206.[CrossRef][Medline]
  2. Aquino, M. H., A. L. Filgueiras, M. C. Ferreira, S. S. Oliveira, M. C. Bastos, and A. Tibana. 2002. Antimicrobial resistance and plasmid profiles of Campylobacter jejuni and Campylobacter coli from human and animal sources. Lett. Appl. Microbiol. 34:149-153.[CrossRef][Medline]
  3. Avrain, L., C. Vernozy-Rozand, and I. Kempf. 2004. Evidence for natural horizontal transfer of tetO gene between Campylobacter jejuni strains in chickens. J. Appl. Microbiol. 97:134-140.[CrossRef][Medline]
  4. Bae, W., K. N. Kaya, D. D. Hancock, D. R. Call, Y. H. Park, and T. E. Besser. 2005. Prevalence and antimicrobial resistance of thermophilic Campylobacter spp. from cattle farms in Washington State. Appl. Environ. Microbiol. 71:169-174.[Abstract/Free Full Text]
  5. Blaser, M. J. 1997. Epidemiologic and clinical features of Campylobacter jejuni infections. J. Infect. Dis. 176:S103-S105.
  6. Engberg, J., F. M. Aarestrup, D. E. Taylor, P. Gerner-Smidt, and I. Nachamkin. 2001. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7:24-34.[Medline]
  7. Gaudreau, C., and H. Gilbert. 1998. Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada. Antimicrob. Agents Chemother. 42:2106-2108.[Abstract/Free Full Text]
  8. Gaudreau, C., and H. Gilbert. 1997. Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli. J. Antimicrob. Chemother. 39:707-712.[Abstract/Free Full Text]
  9. Ge, B., S. Bodeis, R. D. Walker, D. G. White, S. Zhao, P. F. McDermott, and J. Meng. 2002. Comparison of the E-test and agar dilution for in vitro antimicrobial susceptibility testing of Campylobacter. J. Antimicrob. Chemother. 50:487-494.[Abstract/Free Full Text]
  10. Ge, B., D. G. White, P. F. McDermott, W. Girard, S. Zhao, S. Hubert, and J. Meng. 2003. Antimicrobial-resistant Campylobacter species from retail raw meats. Appl. Environ. Microbiol. 69:3005-3007.[Abstract/Free Full Text]
  11. Gibreel, A., D. M. Tracz, L. Nonaka, T. M. Ngo, S. R. Connell, and D. E. Taylor. 2004. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance. Antimicrob. Agents Chemother. 48:3442-3450.[Abstract/Free Full Text]
  12. Health Canada. 2002. Uses of antimicrobials in food animals in Canada: impact on resistance and human health. [Online.] http://www.hc-sc.gc.ca/vetdrugs-medsvet/amr_final_report_june27_tc_e.html.
  13. Helms, M., J. Simonsen, K. E. Olsen, and K. Molbak. 2005. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. J. Infect. Dis. 191:1050-1055.[CrossRef][Medline]
  14. Jacobs-Reitsma, W. F., P. M. Koenraad, N. M. Bolder, and R. W. Mulder. 1994. In vitro susceptibility of Campylobacter and Salmonella isolates from broilers to quinolones, ampicillin, tetracycline, and erythromycin. Vet. Q. 16:206-208.[Medline]
  15. Luo, N., S. Pereira, O. Sahin, J. Lin, S. Huang, L. Michel, and Q. Zhang. 2005. Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc. Natl. Acad. Sci. USA 102:541-546.[Abstract/Free Full Text]
  16. Manavathu, E. K., K. Hiratsuka, and D. E. Taylor. 1988. Nucleotide sequence analysis and expression of a tetracycline-resistance gene from Campylobacter jejuni. Gene 62:17-26.[CrossRef][Medline]
  17. McDermott, P. F., S. M. Bodeis, F. M. Aarestrup, S. Brown, M. Traczewski, P. Fedorka-Cray, M. Wallace, I. A. Critchley, C. Thornsberry, S. Graff, R.Flamm, J. Beyer, D. Shortridge, L. J. Piddock, V. Ricci, M. M. Johnson, R.N.Jones, B. Reller, S. Mirrett, J. Aldrobi, R. Rennie, C. Brosnikoff, L. Turnbull, G. Stein, S. Schooley, R. A. Hanson, and R. D. Walker. 2004. Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb. Drug Resist. 10:124-131.[CrossRef][Medline]
  18. Nachamkin, I., H. Ung, and M. Li. 2002. Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA, 1982-2001. Emerg. Infect. Dis. 8:1501-1503.[Medline]
  19. NCCLS. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, vol. 23. Approved standard M7-A3. NCCLS, Wayne, Pa.
  20. Nirdnoy, W., C. J. Mason, and P. Guerry. 2005. Mosaic structure of a multiple-drug-resistant, conjugative plasmid from Campylobacter jejuni. Antimicrob. Agents Chemother. 49:2454-2459.[Abstract/Free Full Text]
  21. Park, S. F. 2002. The physiology of Campylobacter species and its relevance to their role as foodborne pathogens. Int. J. Food Microbiol. 74:177-188.[CrossRef][Medline]
  22. Pratt, A., and V. Korolik. 2005. Tetracycline resistance of Australian Campylobacter jejuni and Campylobacter coli isolates. J. Antimicrob. Chemother. 55:452-460.[Abstract/Free Full Text]
  23. Randall, L. P., A. M. Ridley, S. W. Cooles, M. Sharma, A. R. Sayers, L. Pumbwe, D. G. Newell, L. J. Piddock, and M. J. Woodward. 2003. Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals. J. Antimicrob. Chemother. 52:507-510.[Abstract/Free Full Text]
  24. Saenz, Y., L. Brinas, E. Dominguez, J. Ruiz, M. Zarazaga, J. Vila, and C. Torres. 2004. Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob. Agents Chemother. 48:3996-4001.[Abstract/Free Full Text]
  25. Taylor, D. E., S. A. De Grandis, M. A. Karmali, and P. C. Fleming. 1981. Transmissible plasmids from Campylobacter jejuni. Antimicrob. Agents Chemother. 19:831-835.[Abstract/Free Full Text]
  26. Tsai, H. J., and P. H. Hsiang. 2005. The prevalence and antimicrobial susceptibilities of Salmonella and Campylobacter in ducks in Taiwan. J. Vet. Med. Sci. 67:7-12.[CrossRef][Medline]
  27. van Boven, M., K. T. Veldman, M. C. de Jong, and D. J. Mevius. 2003. Rapid selection of quinolone resistance in Campylobacter jejuni but not in Escherichia coli in individually housed broilers. J. Antimicrob. Chemother. 52:19-23.
  28. Wang, Y., W. M. Huang, and D. E. Taylor. 1993. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob. Agents Chemother. 37:457-463.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, February 2006, p. 778-780, Vol. 50, No. 2
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.2.778-780.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kos, V. N.
Right arrow Articles by Taylor, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kos, V. N.
Right arrow Articles by Taylor, D. E.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS